Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
Journal of Alzheimer s Disease2018Vol. 65(4), pp. 1225–1236
Citations Over TimeTop 10% of 2018 papers
Jared M. Campbell, Matthew Stephenson, Barbora de Courten, Ian Chapman, Susan Bellman, Edoardo Aromataris
Abstract
Metformin should continue to be used as a first line therapy for diabetes in patients at risk of developing dementia or Alzheimer's disease. The use of metformin by individuals without diabetes for the prevention of dementia is not supported by the available evidence.
Related Papers
- → Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences(2018)251 cited
- A Rare Side Effect of Metformin: Metformin-Induced Hepatotoxicity(2007)
- → Metformin for Prevention of Type 2 Diabetes(2004)11 cited
- Advances in the study on metformin beyond its hypoglycemic effect(2013)
- 당뇨를 동반한 4기 대장암 환자에서 항암약물요법 반응 및 생존율에 대한 Metformin의 효과(2012)